Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sarah Coakeley"'
Autor:
Kristin Flemons, Michael Bosch, Sarah Coakeley, Bushra Muzammal, Rahim Kachra, Shannon M. Ruzycki
Publikováno v:
Perioperative Medicine, Vol 11, Iss 1, Pp 1-12 (2022)
Abstract Background Preoperative medical consultations add expense and burden for patients and the impact of these consults on patient outcomes is conflicting. Previous work suggests that 10–40% of preoperative medical consult recommendations are n
Externí odkaz:
https://doaj.org/article/a898dfbc61d443308640d388cde16186
Autor:
Sarah Coakeley, Antonio P. Strafella
Publikováno v:
npj Parkinson's Disease, Vol 3, Iss 1, Pp 1-9 (2017)
Abstract The recent development of positron emission tomography radiotracers targeting pathological tau in vivo has led to numerous human trials. While investigations have primarily focused on the most common tauopathy, Alzheimer’s disease, it is i
Externí odkaz:
https://doaj.org/article/6afea461ad4e4fbcb28d678c014008db
Autor:
Yuko Koshimori, Sang-Soo Cho, marion criaud, Leigh Christopher, Mark Jacobs, Christine Ghadery, Sarah Coakeley, Madeleine Harris, Romina Mizrahi, Clement Hamani, Lang E Anthony, Sylvain Houle, Antonio Strafella
Publikováno v:
Frontiers in Aging Neuroscience, Vol 8 (2016)
The recent application of graph theory to brain networks promises to shed light on complex diseases such as Parkinson’s disease. This study aimed to investigate functional changes in sensorimotor and cognitive networks in parkinsonian patients, wit
Externí odkaz:
https://doaj.org/article/80b4ca1d46b84e59ae1bf69bacfb6271
Autor:
Yuko Koshimori, Anthony E. Lang, Sarah Coakeley, Pablo Rusjan, Sang Soo Cho, Jinhee Kim, Antonio P. Strafella, Sylvain Houle, Christine Ghadery
Publikováno v:
Brain Structure and Function. 223:589-595
This study investigated binding of [18F]AV-1451 to neuromelanin in the substantia nigra of patients with Parkinson’s disease (PD) and progressive supranuclear palsy (PSP). [18F]AV-1451 is a positron emission tomography radiotracer designed to bind
Autor:
Antonio P. Strafella, Jinhee Kim, Alan A. Wilson, Yuko Koshimori, Pablo Rusjan, Sarah Coakeley, Sang Soo Cho, Madeleine Harris, Christine Ghadery, Anthony E. Lang, Sylvain Houle
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism. 37:3150-3160
Progressive supranuclear palsy is a rare form of atypical Parkinsonism that differs neuropathologically from other parkinsonian disorders. While many parkinsonian disorders such as Parkinson’s disease, Lewy body dementia, and multiple system atroph
Autor:
Yuko Koshimori, Madeleine Harris, Christine Ghadery, Sarah Coakeley, Antonio P. Strafella, Sylvain Houle, Jinhee Kim, Pablo Rusjan
Publikováno v:
Journal of Neuroinflammation. 14
Neuroinflammatory processes including activated microglia have been reported to play an important role in Parkinson’s disease (PD). Increased expression of translocator protein (TSPO) has been observed after brain injury and inflammation in neurode
Publikováno v:
Expert Review of Neurotherapeutics. 14:937-946
Parkinson's disease (PD) is typically known for its cardinal motor symptoms, but a growing body of literature is recognizing a multitude of important nonmotor symptoms as well. Anxiety is one of the most common nonmotor symptoms of PD; unfortunately,
Autor:
Sarah Coakeley, Anthony E. Lang, Lorraine V. Kalia, Sang Soo Cho, Antonio P. Strafella, Sylvain Houle, Lee Cyn Ang, Gerard H. Jansen
Publikováno v:
Movement Disorders. 33:1360-1361
Autor:
Christine, Ghadery, Yuko, Koshimori, Sarah, Coakeley, Madeleine, Harris, Pablo, Rusjan, Jinhee, Kim, Sylvain, Houle, Antonio P, Strafella
Publikováno v:
Journal of Neuroinflammation
Background Neuroinflammatory processes including activated microglia have been reported to play an important role in Parkinson’s disease (PD). Increased expression of translocator protein (TSPO) has been observed after brain injury and inflammation
Autor:
Antonio P. Strafella, Sarah Coakeley
Publikováno v:
Current opinion in neurology. 28(4)
PURPOSE OF REVIEW This review examines the current literature on tau imaging in atypical parkinsonian disorders and other tauopathies. RECENT FINDINGS There are a number of tau PET radiotracers that have demonstrated promising preliminary results in